Publications

Latest publication 03/05/2026

IncRNAs transcriptomics elucidates the potential mechanism of Naoshuantong capsu

Globally, IS causes significant morbidity and is a leading cause of death (Lian et al., 2025;Ding et al., 2022). The pathophysiology of IS involves...

Array
(
    [id_prestablog_news] => 2420
    [id_shop] => 1
    [date] => 2026-03-05 00:00:00
    [date_modification] => 2026-03-05 00:00:00
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 4611
    [id_lang] => 1
    [title] => IncRNAs transcriptomics elucidates the potential mechanism of Naoshuantong capsu
    [paragraph] => IncRNAs transcriptomics elucidates the potential mechanism of Naoshuantong capsule in alleviating synaptic dysfunction in a murine model of cerebral ischemia and reperfusion injury
    [content] => 
Authors
Ke Song, Hongrui Zhang, Haoqi Liu, Yuanyuan Li, Yikun Sun, Xinglu Dong, Chenxi Tao, Yannan He, Zhenhong Liu, Yonghong Gao, Ying Gao

 Lab
Edited by: Yunyao Jiang; Tsinghua University; China; Reviewed by: Sadaf Jahan; Majmaah University; Saudi Arabia; Soad Zakaria; October 6 University; Egypt
Journal
Frontiers in Pharmacology
Abstract
Globally, IS causes significant morbidity and is a leading cause of death (Lian et al., 2025;Ding et al., 2022). The pathophysiology of IS involves complex events, including oxidative stress, inflammation, autophagy, ferroptosis, and apoptosis (Cai et al., 2025;Liu Y. et al., 2025;Liu L. et al., 2025;Zhao H. et al., 2025). Emerging evidence demonstrates that lncRNAs, including ANRIL, MALAT1, and H19, play regulatory functions in these processes during IS (Ding et al., 2025;He P. et al., 2025;Pan et al., 2024). lncRNAs, characterized as transcripts lacking protein-coding potential, actively participate in essential biological processes through transcriptional regulation and post-transcriptional modulation of gene expression (Degirmenci et al., 2019). Numerous studies have demonstrated the therapeutic efficacy of NST in IS, including anti-inflammatory and anti-apoptosis effects, and reduction of cerebral infarction area (Zhang et al., 2019;Luo et al., 2020;Li et al., 2021). It is noteworthy that while prior studies, including work by our team (Xu T. et al., 2025) and others (Luo et al., 2020), have explored a range of doses (e.g., 0.468, 0.936, and up to 1.872 g/kg in Luo et al.), the present study focused specifically on the clinically equivalent dose of 0.468 g/kg. This dose was selected based on body surface area conversion and its established efficacy in ameliorating core pathological features of IS in models. We note that the administration of significantly higher doses (e.g., 1 g/kg/day and above, as occasionally reported in exploratory pharmacological literature) may increase the risk of non-specific effects or artifacts, and such doses require rigorous justification. This study reinforces the evidence for the protective effect of NST treatment in ameliorating IS in mice subjected to cerebral ischemia-reperfusion (MCAO). Our findings validated the successful MCAO model: mice exhibited significant neurological deficits, decreased CBF perfusion, and damage to the cerebral cortex and neurons. We conclusively proved that NST effectively ameliorates brain ischemia/reperfusion injury. However, the exact molecular mechanisms underlying NST’s beneficial effects in IS remain unknown. Therefore, to examine these mechanisms, we conducted microarray analysis to identify differentially expressed genes in the cerebral cortex of MCAO mice following NST treatment.
Keywords/Topics
models; exploratory pharmacological literature; mice; mcao mice; transcriptomics; naoshuantong capsule; synaptic dysfunction; cerebral ischemia reperfusion injury; significant morbidity; death
BIOSEB Instruments Used:
Grip strength test (BIO-GS4)
    [meta_description] => 
    [meta_keywords] => https://pmc.ncbi.nlm.nih.gov/articles/PMC12999579/
    [meta_title] => 
    [link_rewrite] => IncRNAs-transcriptomics-elucidates-the-potential-mechanism-of-Naoshuantong-capsule-in-alleviating-synaptic-dysfunction-in-a-murine-model-of-cerebral-ischemia-and-reperfusion-injury
    [actif_langue] => 1
    [read] => 76
    [count_comments] => 0
    [id] => 2420
    [categories] => Array
        (
            [40] => Array
                (
                    [id_prestablog_categorie] => 40
                    [title] => Ischemic Strokes
                    [link_rewrite] => Ischemic-Strokes
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => IncRNAs transcriptomics elucidates the potential mechanism of Naoshuantong capsule in [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Grip strength test
                    [description_short] => 
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
                )

        )

)
1